What is Hereditary Episodic Ataxia?
At a Glance
Hereditary Episodic Ataxia (EA) is a rare genetic disorder causing temporary episodes of poor balance and coordination due to malfunctioning brain ion channels. It is highly treatable with medication, and genetic testing can identify the specific type, such as EA1 or EA2.
Hereditary Episodic Ataxia (EA) is a rare group of genetic neurological disorders that cause sudden, temporary episodes of poor coordination and balance [1][2]. For many patients, receiving this diagnosis is a moment of profound validation after years of unpredictable symptoms that may have been dismissed or mislabeled as “clumsiness,” “anxiety,” or even “fainting spells” [3]. While the symptoms can feel alarming, understanding the mechanics of the condition is the first step toward regaining a sense of control.
The Three Stabilizing Facts
If you have just been diagnosed, keep these three facts in mind to help orient your path forward:
- There are effective treatments available: EA is one of the more manageable genetic neurological conditions. Many patients find that the right medication can significantly reduce or even eliminate their attacks [1][4].
- It is not “in your head”: Because symptoms come and go, many patients are told their issues are psychological. Your diagnosis confirms there is a physical, genetic reason for what you are experiencing [3].
- The severe “glitch” happens mainly during an attack: While some types of EA involve baseline symptoms or long-term structural changes in the brain, your nervous system typically returns to a more stable state between episodes, and many patients live full, active lives [5].
Understanding “Channelopathies”
To understand EA, it helps to think of your brain as a complex electrical grid. For your nerves to send signals—like telling your legs to walk straight—they use tiny “gates” called ion channels [6]. These gates open and close to let electrical charges (ions) in and out of the cell.
EA is a channelopathy, a type of disorder where these gates are slightly “leaky” or get stuck [6]. When your system is stressed—by fatigue, startle, or exercise—these gates fail to regulate the electricity properly in the cerebellum, the part of the brain that controls movement [7]. This “electrical storm” causes the temporary loss of balance and coordination that defines an attack.
The Spectrum of Episodic Ataxia (EA1–EA9)
Episodic Ataxia is not a single disease but a group of at least nine different types, though EA1 and EA2 are by far the most common [8].
- EA1 (Episodic Ataxia Type 1): Attacks are very brief, usually lasting only seconds to minutes. A unique feature of EA1 is myokymia, which feels like tiny “ripples” or twitching under the skin, often in the hands or around the eyes [8][9].
- EA2 (Episodic Ataxia Type 2): This is the most frequently diagnosed type. Attacks are longer, lasting hours or even days. They are often accompanied by vertigo (spinning sensations), nausea, and a “heavy” feeling in the limbs [5][10].
- Types EA3 through EA9: These are extremely rare and often identified only through specialized genetic testing. They may include additional symptoms like seizures or specific types of migraines [11][12].
Why It Is Often Missed
If it took a long time to get your diagnosis, you are not alone. EA is exceptionally rare; while exact global numbers are difficult to pinpoint, it is estimated to affect roughly 1 in 100,000 people [10].
Because it is so rare, many local doctors may never have seen a case in their entire careers. Furthermore, EA is a “great mimicker” [3]. It is frequently misdiagnosed as:
- Epilepsy: Because some EA patients have “seizure-like” activity on brain scans [13].
- Migraines: Particularly in EA2, where the dizziness feels like a “vestibular migraine” [14].
- Multiple Sclerosis (MS) or Stroke: Due to the sudden onset of coordination issues [3].
Confirming the diagnosis usually requires a combination of a detailed clinical history and genetic testing, which looks for mutations in specific genes like KCNA1 (for EA1) or CACNA1A (for EA2) [11][1]. Knowing your specific type is the key to choosing the most effective treatment plan.
Explore the Guide
To help you navigate your condition, we have organized the following resources:
Recognizing Attacks and Triggers
Learn how to recognize hereditary episodic ataxia (EA) attacks and triggers. Understand the differences between EA1, EA2, and FGF14 symptoms and durations.
The Genetics and Biology of Episodic Ataxia
Learn about the genetics of Hereditary Episodic Ataxia (EA). Understand how KCNA1 and CACNA1A gene mutations cause symptoms and how EA is inherited.
Navigating Your Diagnosis: Genetic Testing and Scans
Learn how hereditary episodic ataxia is diagnosed. Understand why your MRI might be normal, the role of genetic testing, and how to read your lab report.
Treating and Managing Episodic Ataxia
Learn how to treat and manage Hereditary Episodic Ataxia (EA). Understand medications for EA1 and EA2, including acetazolamide, and how to avoid common triggers.
Living with Episodic Ataxia: The Long-Term Outlook
Learn about the long-term prognosis for Hereditary Episodic Ataxia (EA). Understand the differences between EA1 and EA2, and how to manage your daily life.
Common questions in this guide
What does an episodic ataxia attack feel like?
Are my episodic ataxia symptoms just psychological?
What is the difference between EA1 and EA2?
Why is episodic ataxia often misdiagnosed?
How is hereditary episodic ataxia diagnosed?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What was my specific genetic test result, and which type of Episodic Ataxia (e.g., EA1 or EA2) does it confirm?
- 2.What is my risk for developing 'interictal' symptoms—those that persist even between my attacks?
- 3.How much experience do you have treating patients with channelopathies like this?
- 4.What are the most common 'triggers' I should look out for, and how can I track them effectively?
- 5.If I have an attack, what is the protocol for emergency care or notifying your office?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (14)
- 1
Episodic Ataxias: Primary and Secondary Etiologies, Treatment, and Classification Approaches.
Hassan A
Tremor and other hyperkinetic movements (New York, N.Y.) 2023; (13()):9 doi:10.5334/tohm.747.
PMID: 37008993 - 2
The episodic ataxias.
Graves TD, Snell HD, Khodakhah K, et al.
Handbook of clinical neurology 2024; (203()):123-133 doi:10.1016/B978-0-323-90820-7.00012-4.
PMID: 39174244 - 3
Genetic paroxysmal neurological disorders featuring episodic ataxia and epilepsy.
Amadori E, Pellino G, Bansal L, et al.
European journal of medical genetics 2022; (65(4)):104450 doi:10.1016/j.ejmg.2022.104450.
PMID: 35219921 - 4
Fampridine and Acetazolamide in EA2 and Related Familial EA: A Prospective Randomized Placebo-Controlled Trial.
Muth C, Teufel J, Schöls L, et al.
Neurology. Clinical practice 2021; (11(4)):e438-e446 doi:10.1212/CPJ.0000000000001017.
PMID: 34484942 - 5
A novel mutation in CACNA1A gene in a Saudi female with episodic ataxia type 2 with no response to acetazolamide or 4-aminopyridine.
Algahtani H, Shirah B, Algahtani R, et al.
Intractable & rare diseases research 2019; (8(1)):67-71 doi:10.5582/irdr.2018.01133.
PMID: 30881862 - 6
Targeting Ion Channels and Purkinje Neuron Intrinsic Membrane Excitability as a Therapeutic Strategy for Cerebellar Ataxia.
Huang H, Shakkottai VG
Life (Basel, Switzerland) 2023; (13(6)) doi:10.3390/life13061350.
PMID: 37374132 - 7
Ion channelopathies to bridge molecular lesions, channel function, and clinical therapies.
Carbone E, Mori Y
Pflugers Archiv : European journal of physiology 2020; (472(7)):733-738 doi:10.1007/s00424-020-02424-y.
PMID: 32607810 - 8
Episodic ataxia type 2 (EA2) with interictal myokymia and focal dystonia.
Nielsen EN, Ásbjörnsdóttir B, Møller LB, et al.
Cold Spring Harbor molecular case studies 2022; (8(6)) doi:10.1101/mcs.a006236.
PMID: 36307210 - 9
A Common Kinetic Property of Mutations Linked to Episodic Ataxia Type 1 Studied in the Shaker Kv Channel.
Zhao J, Petitjean D, Haddad GA, et al.
International journal of molecular sciences 2020; (21(20)) doi:10.3390/ijms21207602.
PMID: 33066705 - 10
Next-generation sequencing identifies novel CACNA1A gene mutations in episodic ataxia type 2.
Maksemous N, Roy B, Smith RA, Griffiths LR
Molecular genetics & genomic medicine 2016; (4(2)):211-22 doi:10.1002/mgg3.196.
PMID: 27066515 - 11
Diagnostic value of genetic testing, with focus on CACNA1A, in children with episodic neurologic disorders: a single-centre retrospective study.
Chinigioli M, Martí-Sanchez L, Yubero D, et al.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2025; (60()):50-57 doi:10.1016/j.ejpn.2025.11.005.
PMID: 41370964 - 12
Compound heterozygosity with PRRT2: Pushing the phenotypic envelope in genetic epilepsies.
El Achkar CM, Rosen Sheidley B, O'Rourke D, et al.
Epilepsy & behavior case reports 2019; (11()):125-128 doi:10.1016/j.ebcr.2016.12.001.
PMID: 31193310 - 13
Episodic ataxia type 2 manifests as epileptiform electroencephalographic activity with no epileptic attacks in two family members.
Kaido M, Furuta M, Nakamori M, et al.
Rinsho shinkeigaku = Clinical neurology 2016; (56(4)):260-4 doi:10.5692/clinicalneurol.cn-000854.
PMID: 27025991 - 14
Epilepsy and episodic ataxia type 2: family study and review of the literature.
Verriello L, Pauletto G, Nilo A, et al.
Journal of neurology 2021; (268(11)):4296-4302 doi:10.1007/s00415-021-10555-0.
PMID: 33983550
This information is for educational purposes only and should not replace professional medical advice. Always consult your neurologist or genetic counselor regarding your episodic ataxia symptoms, diagnosis, and treatment plan.
Get notified when new evidence is published on Hereditary episodic ataxia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.